TrialFind
Saved trials
Back to results
Completed
Phase 2
MK0249 for the Symptomatic Treatment of Alzheimer's Disease (MK0249-011)
NCT00420420
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
View on ClinicalTrials.gov
Official details
MK0249 for the Symptomatic Treatment of Alzheimer's Disease (MK0249-011) — TrialFind